Compare Aurobindo Pharma with ANUH PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ANUH PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ANUH PHARMA AUROBINDO PHARMA/
ANUH PHARMA
 
P/E (TTM) x 7.5 26.9 28.0% View Chart
P/BV x 1.8 2.7 66.3% View Chart
Dividend Yield % 0.6 1.5 40.9%  

Financials

 AUROBINDO PHARMA   ANUH PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
ANUH PHARMA
Mar-21
AUROBINDO PHARMA/
ANUH PHARMA
5-Yr Chart
Click to enlarge
High Rs1,023219 467.9%   
Low Rs33354 620.3%   
Sales per share (Unadj.) Rs422.886.2 490.5%  
Earnings per share (Unadj.) Rs92.05.7 1,620.8%  
Cash flow per share (Unadj.) Rs110.08.7 1,266.6%  
Dividends per share (Unadj.) Rs4.001.50 266.7%  
Avg Dividend yield %0.61.1 53.6%  
Book value per share (Unadj.) Rs374.338.0 983.7%  
Shares outstanding (eoy) m585.9450.11 1,169.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.61.6 101.5%   
Avg P/E ratio x7.424.0 30.7%  
P/CF ratio (eoy) x6.215.7 39.3%  
Price / Book Value ratio x1.83.6 50.6%  
Dividend payout %4.326.4 16.5%   
Avg Mkt Cap Rs m397,3986,826 5,822.3%   
No. of employees `000NANA-   
Total wages/salary Rs m35,350143 24,736.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m247,7464,320 5,735.4%  
Other income Rs m3,809105 3,614.1%   
Total revenues Rs m251,5554,425 5,684.9%   
Gross profit Rs m81,480451 18,058.9%  
Depreciation Rs m10,554151 7,000.5%   
Interest Rs m74520 3,669.5%   
Profit before tax Rs m73,990386 19,192.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,098101 19,869.2%   
Profit after tax Rs m53,892284 18,952.0%  
Gross profit margin %32.910.4 314.9%  
Effective tax rate %27.226.2 103.5%   
Net profit margin %21.86.6 330.4%  
BALANCE SHEET DATA
Current assets Rs m198,2352,377 8,338.7%   
Current liabilities Rs m106,6521,395 7,647.0%   
Net working cap to sales %37.022.7 162.5%  
Current ratio x1.91.7 109.0%  
Inventory Days Days1929 65.8%  
Debtors Days Days52903 5.7%  
Net fixed assets Rs m135,778949 14,306.1%   
Share capital Rs m586251 233.8%   
"Free" reserves Rs m218,7131,656 13,208.3%   
Net worth Rs m219,2991,906 11,503.0%   
Long term debt Rs m1,6840-   
Total assets Rs m334,0133,326 10,041.3%  
Interest coverage x100.320.0 501.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.3 57.1%   
Return on assets %16.49.2 178.6%  
Return on equity %24.614.9 164.8%  
Return on capital %33.821.3 158.9%  
Exports to sales %53.849.2 109.3%   
Imports to sales %16.467.8 24.2%   
Exports (fob) Rs m133,2482,125 6,270.5%   
Imports (cif) Rs m40,6152,927 1,387.4%   
Fx inflow Rs m133,2482,125 6,270.5%   
Fx outflow Rs m44,9462,927 1,535.4%   
Net fx Rs m88,302-802 -11,006.1%   
CASH FLOW
From Operations Rs m33,289-187 -17,768.5%  
From Investments Rs m5,987522 1,146.8%  
From Financial Activity Rs m-13,648-331 4,121.4%  
Net Cashflow Rs m25,8314 731,753.5%  

Share Holding

Indian Promoters % 48.8 70.4 69.3%  
Foreign collaborators % 3.1 0.0 30,700.0%  
Indian inst/Mut Fund % 37.2 0.0 -  
FIIs % 21.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 29.6 162.9%  
Shareholders   329,940 22,779 1,448.4%  
Pledged promoter(s) holding % 24.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   ASTRAZENECA PHARMA  VIVIMED LABS  WANBURY  BDH INDUS.  VAISHALI PHARMA   



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

ANUH PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 27, 2021 | Updated on Oct 27, 2021

Here's an analysis of the annual report of ANUH PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ANUH PHARMA. Also includes updates on the valuation of ANUH PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Dec 3, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS